Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chubb
QuintilesIMS
Mallinckrodt
Cipla
McKinsey

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 8,829,020

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,829,020
Title:Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
Abstract: The invention relates generally to anti-angiogenesis agents and related methods of using to anti-angiogenesis agents for biomedical applications including direct monotherapy and combination therapy for treatment of an angiogenesis related condition. In an embodiment, the invention provides a class of opioid compounds and structurally related opioid derivatives exhibiting anti-VEGF activity for use in therapeutic procedures, including phototherapy. Opioid compounds and structurally related opioid derivatives of the invention may be administered alone or in combination with administration of a phototherapy agent and/or other therapeutic agent.
Inventor(s): Cantrell; Gary L. (Troy, IL), Rajagopalan; Raghavan (St. Peters, MO), Berberich; David W. (St. Peters, MO), Karwa; Amolkumar (St. Charles, MO), Dorshow; Richard B. (St. Louis, MO)
Assignee: Mallinckrodt LLC (Hazelwood, MO)
Application Number:13/383,243
Patent Claims:see list of patent claims

Details for Patent 8,829,020

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Mallinckrodt LLC (Hazelwood, MO) 2029-07-16 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Mallinckrodt LLC (Hazelwood, MO) 2029-07-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Chubb
Baxter
Chinese Patent Office
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.